Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Assets (2016 - 2025)

Historic Current Assets for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $142.2 million.

  • AC Immune's Current Assets fell 3432.83% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year decrease of 3432.83%. This contributed to the annual value of $196.3 million for FY2024, which is 9986.08% down from last year.
  • As of Q3 2025, AC Immune's Current Assets stood at $142.2 million, which was down 3432.83% from $159.2 million recorded in Q2 2025.
  • AC Immune's Current Assets' 5-year high stood at $243.9 billion during Q1 2021, with a 5-year trough of $97.6 million in Q3 2023.
  • Moreover, its 5-year median value for Current Assets was $169.2 million (2025), whereas its average is $54.8 billion.
  • Per our database at Business Quant, AC Immune's Current Assets crashed by 9993.95% in 2022 and then surged by 10601249.63% in 2023.
  • Over the past 5 years, AC Immune's Current Assets (Quarter) stood at $219.8 billion in 2021, then crashed by 99.94% to $133.0 million in 2022, then soared by 106012.5% to $141.1 billion in 2023, then plummeted by 99.86% to $196.3 million in 2024, then dropped by 27.58% to $142.2 million in 2025.
  • Its Current Assets was $142.2 million in Q3 2025, compared to $159.2 million in Q2 2025 and $169.2 million in Q1 2025.